FDA Delay in Banning Propoxyphene (Darvon) May Have Caused Thousands of Deaths
The FDA finally pulled the sometimes-deadly defective product propoxyphene (sold under the brand names Darvon and Darvocet in the US) from the market. However, the delay in pulling the drug from the market may have caused several deaths. The medical community has expressed serious concerns over the drug for most of the 50 years it has been on the market. Not only is propoxyphene not very effective as a painkiller, but the drug is highly addictive and, most importantly, it can be toxic even at low levels.
Too Risky for US
The product defect is so dangerous that toxicity and the risk of causing abnormal heart rhythms have caused thousands of deaths in patients who took these medications that the United Kingdom banned the drug in 2005 and the entire European Union followed suit in January of 2009. In the US, it was not until last week that the FDA finally pulled the plug on the brand-name propoxyphene drugs, Darvon and Darvocet, as well as their generic surrogates.
Too Little, Too Late
For thousands of Americans, the FDA's action comes decades too late. Back in 1978 the consumer group Public Citizen first petitioned U.S. regulators to remove the drug from the market. Given the body of evidence, the 30-year old questions about propoxyphene, and the U.K.'s and European Union's decisions to ban the drug, you have to wonder: why did it take so long to ban the drug here? The FDA said they needed more time to research the drug's success rate and safety, and said the recommended dose caused, "significant changes to the electrical activity of the heart," which can, "increase the risk for serious abnormal heart rhythms that have been linked to serious adverse effects, including sudden death."
The drug was approved 53 years ago, and the FDA has just now found the drug unsafe, and even taking the proper dosage can cause sudden death.
What to Do if You Have Been Affected
If you or a love one has experienced side effects due to a defective medication, call a Bisnar | Chase Personal Injury Attorneys, LLP Los Angeles pharmaceutical litigation attorney for a free professional evaluation of your case by attorneys who have represented over 6,000 clients since 1978. Bisnar | Chase Personal Injury Attorneys, LLP pride themselves on putting their clients first and obtaining the highest possible recovery for victims of pharmaceutical company negligence.
Bisnar | Chase Personal Injury Attorneys, LLP partners, John Bisnar and Brian Chase, have shown their superior legal representation time and time again, and their results don't lie. Brian Chase has tried over twenty jury trials and, in the last couple of years, has entered into numerous seven and eight-figure settlements. In 2004, Brian was named the Trial Lawyer of the Year, and his dedication to holding corporate America responsible for defective products has been nothing short of inspiring. If you have suffered catastrophic injuries at the hands of these negligent pharmaceutical companies you will need an attorney who consistently gets results. Bisnar | Chase Personal Injury Attorneys, LLP will get you from victim to victor with as little pain as possible.
Call your best friends in the legal industry after a car accident at 949-203-3814. The call is free. The advice may be priceless.
Call our personal injury lawyers in Los Angeles for a free professional evaluation of your case by attorneys who have represented over 6,000 clients since 1978. You will experience awarding winning representation and outstanding personal service by a friendly law firm in a comfortable environment.